Sensus Healthcare, Inc. (SRTS) shareholders
SRTSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 9/3043% below fair value
$2.33−0.90 (-27.80%)
Close on Nov 13, 2026Market cap $38.27MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
22.2%
4M of 16M shares
Institutional holders
38
4 new, 6 sold out
Net institutional buying
-0M
In Q2 2026
Insider trades, 12 months
13 buys · 0 sales
Net bought $708.19K
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Edwin L. Solot, Jr. | 1,245,280 | 7.60% | 13G (passive) amendment | Dec 31, 2024 |
| Joseph C. Sardano | 1,175,293 | 7.10% | 13G (passive) amendment | Sep 14, 2023 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of SRTS | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Pacific Ridge Capital Partners, LLC | 789,675 | 4.80% | $2.38M | −6,397 | 0.43% |
| Vanguard Capital Management LLC | 660,402 | 4.01% | $1.99M | +12,177 | 0.00% |
| Dimensional Fund Advisors LP | 316,121 | 1.92% | $954.76K | −71,271 | 0.00% |
| Divisadero Street Capital Management, LP | 278,485 | 1.69% | $841.03K | −7,593 | 0.02% |
| Renaissance Technologies LLC | 242,334 | 1.47% | $731.85K | −9,900 | 0.00% |
| Geode Capital Management, LLC | 154,152 | 0.94% | $465.66K | −11,398 | 0.00% |
| UBS Group AG | 152,573 | 0.93% | $460.77K | −20,297 | 0.00% |
| Sachetta, LLC | 152,008 | 0.92% | $459.07K | +1,500 | 0.22% |
| Greenline Wealth Management LLC | 128,774 | 0.78% | $388.90K | – | 0.32% |
| North Star Investment Management Corp. | 125,586 | 0.76% | $379.27K | – | 0.02% |
| Bank of New York Mellon Corp | 100,410 | 0.61% | $303.24K | – | 0.00% |
| BlackRock, Inc. | 83,555 | 0.51% | $252.34K | +12,388 | 0.00% |
| Vanguard Fiduciary Trust Co | 76,289 | 0.46% | $230.39K | +559 | 0.00% |
| State Street Corp | 69,252 | 0.42% | $209.14K | – | 0.00% |
| Ingalls & Snyder LLC | 55,000 | 0.33% | $166.00K | – | 0.00% |
| Mindset Wealth Management, LLC | 52,100 | 0.32% | $157.34K | – | 0.03% |
| Janney Montgomery Scott LLC | 40,576 | 0.25% | $123.00K | – | 0.00% |
| Northern Trust Corp | 28,187 | 0.17% | $85.13K | −40,006 | 0.00% |
| Chapin Davis, Inc. | 26,000 | 0.16% | $78.52K | – | 0.01% |
| American Century Companies Inc | 21,272 | 0.13% | $64.24K | – | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 38 | 4M | 22.2% | 4 / 8 | 12 / 6 | 0M | 0M |
| Q1 2026 | 41 | 4M | 24.0% | 7 / 9 | 11 / 9 | 1M | 0M |
| Q4 2025 | 45 | 4M | 25.4% | 8 / 8 | 14 / 5 | 1M | 1M |
| Q3 2025 | 42 | 4M | 25.6% | 3 / 10 | 14 / 7 | 0M | 1M |
| Q2 2025 | 46 | 4M | 26.6% | 4 / 22 | 13 / 11 | 1M | 0M |
| Q1 2025 | 53 | 4M | 24.5% | 12 / 17 | 17 / 24 | 1M | 2M |
| Q4 2024 | 65 | 5M | 29.8% | 17 / 27 | 11 / 1 | 1M | 0M |
| Q3 2024 | 50 | 4M | 23.6% | 8 / 16 | 15 / 4 | 1M | 0M |
| Q2 2024 | 47 | 3M | 19.9% | 13 / 17 | 8 / 11 | 1M | 0M |
| Q1 2024 | 45 | 2M | 15.1% | 11 / 5 | 16 / 7 | 0M | 1M |
| Q4 2023 | 41 | 3M | 17.1% | 6 / 10 | 14 / 5 | 0M | 0M |
| Q3 2023 | 40 | 3M | 16.2% | 1 / 7 | 17 / 10 | 0M | 1M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
30 funds held SRTS in Q2 2026, 47% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of SRTS | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 494,131 | 3.00% | $1.49M | 0.00% | Jun 30, 2026 |
| Adara Smaller Companies Fund | 310,940 | 1.89% | $960.80K | 0.12% | May 31, 2026 |
| Vanguard Extended Market Index Fund | 154,670 | 0.94% | $467.10K | 0.00% | Jun 30, 2026 |
| M3Sixty Income and Opportunity Fund | 143,000 | 0.87% | $441.87K | 2.64% | May 31, 2026 |
| North Star Micro Cap Fund | 125,586 | 0.76% | $388.06K | 0.21% | May 31, 2026 |
| Fidelity Extended Market Index Fund | 77,130 | 0.47% | $238.33K | 0.00% | May 31, 2026 |
| U.S. Small Cap Portfolio | 75,124 | 0.46% | $218.61K | 0.00% | Jul 31, 2026 |
| iShares Micro-Cap ETF | 46,361 | 0.28% | $140.01K | 0.01% | Jun 30, 2026 |
| U.S. Small Cap Value Portfolio | 45,206 | 0.27% | $131.55K | 0.00% | Jul 31, 2026 |
| Dimensional U.S. Small Cap ETF | 29,133 | 0.18% | $84.78K | 0.00% | Jul 31, 2026 |
| Dimensional US Small Cap Value ETF | 28,566 | 0.17% | $83.13K | 0.00% | Jul 31, 2026 |
| Fidelity Total Market Index Fund | 24,723 | 0.15% | $76.39K | 0.00% | May 31, 2026 |
| U.S. Core Equity 2 Portfolio | 22,487 | 0.14% | $65.44K | 0.00% | Jul 31, 2026 |
| Dimensional U.S. Core Equity 2 ETF | 21,580 | 0.13% | $62.80K | 0.00% | Jul 31, 2026 |
| Fidelity Series Total Market Index Fund | 20,910 | 0.13% | $64.61K | 0.00% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Joseph C. Sardano | CHIEF EXECUTIVE OFFICER, Director | 1,220,293 | 7.41% | Aug 24, 2026 |
| Michael Sardano | PRESIDENT AND GENERAL COUNSEL, Director | 159,839 | 0.97% | Dec 16, 2025 |
| Javier Rampolla | CHIEF FINANCIAL OFFICER | 48,114 | 0.29% | Apr 22, 2026 |
| Magdalena Martinez | CHIEF OPERATING OFFICER | 12,754 | 0.08% | Apr 22, 2026 |
| Carlton Chow | Chief Technology Officer | – | – | Jun 10, 2025 |
| Eric Sachetta | Director | 296,877 | 1.80% | Aug 31, 2026 |
| Larry Joseph Biscotti | Director | – | – | Feb 18, 2026 |
| Megan Cornish | Director | 32,000 | 0.19% | Dec 19, 2024 |
| William H. McCall | Director | 355,723 | 2.16% | Dec 19, 2024 |
| Anthony Benedict Petrelli | Director | 66,466 | 0.40% | Dec 19, 2024 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Eric Sachetta Director | Aug 31, 2026 | Buy | +27,304 | $3.54 | $96.66K | 294,784 |
| Eric Sachetta Director | Aug 28, 2026 | Buy | +37,537 | $3.44 | $129.13K | 267,480 |
| Eric Sachetta Director | Aug 27, 2026 | Buy | +10,925 | $3.18 | $34.74K | 229,943 |
| Eric Sachetta Director | Aug 26, 2026 | Buy | +9,708 | $3.29 | $31.94K | 219,018 |
| Eric Sachetta Director | Aug 24, 2026 | Buy | +34,697 | $3.25 | $112.77K | 209,310 |
| Eric Sachetta Director | Aug 21, 2026 | Buy | +7,000 | $3.25 | $22.75K | 174,613 |
| Joseph C. Sardano CHIEF EXECUTIVE OFFICER, Director | Aug 20, 2026 | Buy | +20,000 | $3.02 | $60.40K | 1,220,293 |
| Eric Sachetta Director | Aug 20, 2026 | Buy | +24,000 | $3.13 | $75.12K | 167,613 |
| Eric Sachetta Director | May 12, 2026 | Buy | +1,500 | $3.34 | $5.01K | 143,613 |
| Eric Sachetta Director | Feb 24, 2026 | Buy | +2,000 | $3.81 | $7.62K | 142,113 |
| Michael Sardano PRESIDENT AND GENERAL COUNSEL, Director | Dec 12, 2025 | Award | +40,000 | – | – | 158,839 |
| Eric Sachetta Director | Nov 21, 2025 | Buy | +7,000 | $3.93 | $27.51K | 140,113 |
| Joseph C. Sardano CHIEF EXECUTIVE OFFICER, Director | Nov 18, 2025 | Buy | +25,000 | $4.03 | $100.75K | 1,200,293 |
| Michael Sardano PRESIDENT AND GENERAL COUNSEL, Director | Nov 18, 2025 | Buy | +1,000 | $3.80 | $3.80K | 118,839 |
| Eric Sachetta Director | Nov 13, 2025 | Buy | +2,500 | $4.50 | $11.25K | 133,113 |
| Michael Sardano PRESIDENT AND GENERAL COUNSEL, Director | Nov 11, 2025 | Buy | +766 | $4.27 | $3.27K | 766 |
| Michael Sardano PRESIDENT AND GENERAL COUNSEL, Director | Nov 11, 2025 | Buy | +1,000 | $4.26 | $4.26K | 117,839 |
| Michael Sardano PRESIDENT AND GENERAL COUNSEL, Director | Nov 11, 2025 | Buy | +234 | $4.34 | $1.02K | 1,000 |
| Michael Sardano PRESIDENT AND GENERAL COUNSEL, Director | Nov 11, 2025 | Buy | +234 | $4.24 | $992 | 118,839 |
| Michael Sardano PRESIDENT AND GENERAL COUNSEL, Director | Nov 11, 2025 | Buy | +1,000 | $4.26 | $4.26K | 117,839 |
| Michael Sardano PRESIDENT AND GENERAL COUNSEL, Director | Nov 11, 2025 | Buy | +766 | $4.27 | $3.27K | 118,605 |
| Michael Sardano PRESIDENT AND GENERAL COUNSEL, Director | Nov 11, 2025 | Buy | +1,000 | $4.26 | $4.26K | 117,839 |
| Michael Sardano PRESIDENT AND GENERAL COUNSEL, Director | Aug 13, 2025 | Buy | +1,000 | $3.37 | $3.37K | 116,839 |
| Javier Rampolla CHIEF FINANCIAL OFFICER | Feb 10, 2025 | Buy | +501 | $5.95 | $2.98K | 40,745 |
| Michael Sardano PRESIDENT AND GENERAL COUNSEL, Director | Feb 10, 2025 | Buy | +1,000 | $5.95 | $5.95K | 115,839 |
| Anthony Benedict Petrelli Director | Dec 17, 2024 | Award | +20,000 | – | – | 66,466 |
| Megan Cornish Director | Dec 17, 2024 | Award | +20,000 | – | – | 32,000 |
| Michael Sardano PRESIDENT AND GENERAL COUNSEL, Director | Dec 17, 2024 | Award | +40,000 | – | – | 114,839 |
| William H. McCall Director | Dec 17, 2024 | Award | +20,000 | – | – | 30,000 |
| Michael Sardano PRESIDENT AND GENERAL COUNSEL, Director | Jul 21, 2024 | Tax withholding | −3,935 | $6.00 | $23.61K | 74,839 |
| Javier Rampolla CHIEF FINANCIAL OFFICER | Jul 21, 2024 | Tax withholding | −3,935 | $6.00 | $23.61K | 40,244 |
| John Heinrich Director | May 20, 2024 | Sale | −15,227 | $6.24 | $95.02K | 59,940 |
| John Heinrich Director | May 17, 2024 | Sale | −4,773 | $5.95 | $28.40K | 75,167 |
| Michael Sardano PRESIDENT AND GENERAL COUNSEL | Jan 11, 2024 | Award | +20,000 | – | – | 78,774 |
| Magdalena Martinez CHIEF OPERATING OFFICER | Dec 19, 2023 | Tax withholding | −741 | $2.66 | $1.97K | 12,013 |
| Magdalena Martinez CHIEF OPERATING OFFICER | Dec 19, 2023 | Tax withholding | −741 | $2.66 | $1.97K | 9,759 |
| Joseph C. Sardano CHIEF EXECUTIVE OFFICER, Director | Sep 14, 2023 | Buy | +10,000 | $2.88 | $28.80K | 1,175,293 |
| Michael Sardano PRESIDENT AND GENERAL COUNSEL | Aug 28, 2023 | Buy | +1,000 | $2.99 | $2.99K | 58,774 |
| Michael Sardano PRESIDENT AND GENERAL COUNSEL | Aug 8, 2023 | Buy | +1,000 | $3.78 | $3.78K | 57,774 |
| Joseph C. Sardano CHIEF EXECUTIVE OFFICER, Director | Aug 8, 2023 | Buy | +10,000 | $3.86 | $38.60K | 1,165,293 |
| Javier Rampolla CHIEF FINANCIAL OFFICER | Jul 31, 2023 | Tax withholding | −3,935 | $3.03 | $11.92K | 44,179 |
| John Heinrich Director | May 11, 2023 | Buy | +10,000 | $2.86 | $28.60K | 79,940 |
| Joseph C. Sardano CHIEF EXECUTIVE OFFICER, Director | May 10, 2023 | Buy | +7,925 | $3.00 | $23.78K | 1,155,293 |
| Joseph C. Sardano CHIEF EXECUTIVE OFFICER, Director | May 9, 2023 | Buy | +17,075 | $2.99 | $51.05K | 1,147,368 |
| Samuel O'Rear Director | May 9, 2023 | Buy | +17,564 | $3.00 | $52.69K | 143,570 |
| Michael Sardano PRESIDENT AND GENERAL COUNSEL | May 8, 2023 | Buy | +1,000 | $3.00 | $3.00K | 56,774 |
| Samuel O'Rear Director | May 8, 2023 | Buy | +2,436 | $2.95 | $7.19K | 126,006 |
| Javier Rampolla CHIEF FINANCIAL OFFICER | Feb 1, 2023 | Tax withholding | −742 | $8.84 | $6.56K | 48,114 |
| Michael Sardano PRESIDENT AND GENERAL COUNSEL | Jan 26, 2023 | Tax withholding | −3,745 | $8.96 | $33.56K | 55,774 |
| Michael Sardano PRESIDENT AND GENERAL COUNSEL | Jan 26, 2023 | Award | +10,000 | – | – | 59,519 |
| Michael Sardano PRESIDENT AND GENERAL COUNSEL | Sep 13, 2022 | Option exercise | +5,000 | $5.55 | $27.75K | 54,519 |
| Michael Sardano PRESIDENT AND GENERAL COUNSEL | Sep 13, 2022 | Sale | −5,000 | $14.13 | $70.65K | 49,519 |
| Joseph C. Sardano Chief Executive Officer, Director | Sep 7, 2022 | Sale | −15,794 | $12.58 | $198.69K | 1,130,293 |
| Joseph C. Sardano Chief Executive Officer, Director | Sep 6, 2022 | Sale | −15,794 | $12.56 | $198.37K | 1,146,087 |
| Joseph C. Sardano Chief Executive Officer, Director | Sep 2, 2022 | Sale | −10,000 | $12.42 | $124.20K | 1,161,881 |
| Joseph C. Sardano CHIEF EXECUTIVE OFFICER, Director | Aug 11, 2022 | Sale | −28,999 | $14.21 | $412.08K | 1,171,881 |
| Joseph C. Sardano CHIEF EXECUTIVE OFFICER, Director | Aug 10, 2022 | Sale | −93,320 | $14.16 | $1.32M | 1,200,880 |
| Samuel O'Rear Director | Aug 10, 2022 | Sale | −39,978 | $14.26 | $570.09K | 123,570 |
| Joseph C. Sardano CHIEF EXECUTIVE OFFICER, Director | Aug 9, 2022 | Sale | −36,093 | $13.97 | $504.22K | 1,294,200 |
| Samuel O'Rear Director | Aug 9, 2022 | Sale | −10,022 | $13.96 | $139.91K | 163,548 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Short % of float
1.56%
0M shares short
Days to cover
7.2
At 0M shares a day
Change since last report
-3.3%
From 0M shares
Short volume, 20 days
60.6%
Of volume reported to FINRA
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Sensus Healthcare's stock actually held short. Settlement fails (shares not delivered on time) peaked at 2,334 shares on Aug 25, 2026 over the last 90 days.
See a number that looks wrong?